Allergan, Argentum settle patent dispute over eye drug Restasis

(Reuters) - U.S. generic drug company Argentum Pharmaceuticals LLC said on Tuesday it had reached an agreement with Allergan Plc that settles a patent dispute over the generic version of Allergan's eye drug, Restasis.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news

Related Links:

Authors: Yousefi A, Nasehi S, Arshi S, Nabavi M, Bemanian MH, Shokri S, Seif F, Khoshmirsafa M, Saeedi Y, Rajabian B, Mahjoub F, Sadeghian M, Talachian E, Fallahpour M PMID: 32496031 [PubMed - as supplied by publisher]
Source: European Annals of Allergy and Clinical Immunology - Category: Allergy & Immunology Tags: Eur Ann Allergy Clin Immunol Source Type: research
Authors: Skander D, Allenova A, Maurer M, Kolkhir P PMID: 32496030 [PubMed - as supplied by publisher]
Source: European Annals of Allergy and Clinical Immunology - Category: Allergy & Immunology Tags: Eur Ann Allergy Clin Immunol Source Type: research
Publication date: Available online 4 June 2020Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Roberto Padoan, Fulvia Chieco Bianchi, Maria Rita Marchi, Diego Cazzador, Mara Felicetti, Enzo Emanuelli, Andrea Vianello, Piero Nicolai, Andrea Doria, Franco Schiavon
Source: The Journal of Allergy and Clinical Immunology: In Practice - Category: Allergy & Immunology Source Type: research
Despite important implications in the management of MS, clinicians often have little training or knowledge of the wide variations of cannabis.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Neurology & Neurosurgery News Source Type: news
An acid-hydrolyzed wheat protein activates the inflammatory and NF-κB pathways leading to long TSLP transcription in human keratinocytes. J Toxicol Sci. 2020;45(6):327-337 Authors: Kuroda Y, Yuki T, Takahashi Y, Sakaguchi H, Matsunaga K, Itagaki H Abstract Hydrolyzed wheat proteins (HWPs) contained in cosmetics have occasionally caused immediate-type hypersensitivity following repeated skin exposure. Although the Cosmetic Ingredient Review Expert Panel concluded that
Source: Journal of Toxicological Sciences - Category: Toxicology Tags: J Toxicol Sci Source Type: research
George Lundberg discusses why the cause of death matters.Medscape Internal Medicine
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Infectious Diseases Commentary Source Type: news
Allergists and immunologists dove into telemedicine'overnight'when the COVID crisis started, and they like it, but regulations will need to change before its use becomes permanent.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Allergy & Clinical Immunology News Source Type: news
Read clinically focused news coverage of key developments from EAACI 2020Medscape Allergy &Immunology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Conference Coverage Source Type: news
Dr David Johnson on important new recommendations for managing and treating this once poorly researched disease.Medscape Gastroenterology
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Gastroenterology Commentary Source Type: news
Conditions:   Keratoconus;   Dry Eye;   Allergy Intervention:   Drug: dexamethasone ophthalmic insert 0.4 mg, for intracanalicular use Sponsor:   Illinois College of Optometry Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Allergy | Health | Restasis